{"id":"https://openalex.org/W2135326558","doi":"https://doi.org/10.1158/1078-0432.ccr-07-0527","title":"Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling","display_name":"Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling","alternate_titles":[],"publication_year":2007,"publication_date":"2007-12-01","ids":{"openalex":"https://openalex.org/W2135326558","doi":"https://doi.org/10.1158/1078-0432.ccr-07-0527","mag":"2135326558","pmid":"https://pubmed.ncbi.nlm.nih.gov/18056185"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-07-0527","doi":"https://doi.org/10.1158/1078-0432.ccr-07-0527","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-0527","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2135326558"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108146416","display_name":"Jeffrey Haessler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101190","display_name":"Cancer Research And Biostatistics","ror":"https://ror.org/01575p865","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210101190"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeffrey Haessler","raw_affiliation_strings":["1Cancer Research and Biostatistics, Seattle, Washington and","Cancer Research and Biostatistics, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research and Biostatistics, Seattle, Washington and","institution_ids":["https://openalex.org/I4210101190"]},{"raw_affiliation_string":"Cancer Research and Biostatistics, Seattle, Washington, USA","institution_ids":["https://openalex.org/I4210101190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027806317","display_name":"John D. Shaughnessy","orcid":"https://orcid.org/0000-0002-2017-6236","observed_orcids":["https://orcid.org/0000-0002-2017-6236"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John D. Shaughnessy","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002787785","display_name":"Fenghuang Zhan","orcid":"https://orcid.org/0000-0001-6208-1676","observed_orcids":["https://orcid.org/0000-0001-6208-1676"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fenghuang Zhan","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103408877","display_name":"John J. Crowley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101190","display_name":"Cancer Research And Biostatistics","ror":"https://ror.org/01575p865","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210101190"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Crowley","raw_affiliation_strings":["1Cancer Research and Biostatistics, Seattle, Washington and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research and Biostatistics, Seattle, Washington and","institution_ids":["https://openalex.org/I4210101190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038021934","display_name":"Joshua Epstein","orcid":"https://orcid.org/0000-0002-8553-1358","observed_orcids":["https://orcid.org/0000-0002-8553-1358"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joshua Epstein","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090044223","display_name":"Frits van Rhee","orcid":"https://orcid.org/0000-0001-9959-1282","observed_orcids":["https://orcid.org/0000-0001-9959-1282"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frits van Rhee","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108381242","display_name":"Elias J. Anaissie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elias Anaissie","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063151492","display_name":"Mauricio Pineda\u2010Roman","orcid":"https://orcid.org/0000-0002-0028-3720","observed_orcids":["https://orcid.org/0000-0002-0028-3720"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mauricio Pineda-Roman","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087775484","display_name":"Maurizio Zangari","orcid":"https://orcid.org/0000-0002-1720-3854","observed_orcids":["https://orcid.org/0000-0002-1720-3854"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maurizio Zangari","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083620756","display_name":"Klaus A. Hollmig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Klaus Hollmig","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103721901","display_name":"Abid Mohiuddin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Abid Mohiuddin","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110085052","display_name":"Yazan M. Alsayed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yazan Alsayed","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040237587","display_name":"Antje Hoering","orcid":"https://orcid.org/0000-0002-4709-3027","observed_orcids":["https://orcid.org/0000-0002-4709-3027"]},"institutions":[{"id":"https://openalex.org/I4210101190","display_name":"Cancer Research And Biostatistics","ror":"https://ror.org/01575p865","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210101190"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Antje Hoering","raw_affiliation_strings":["1Cancer Research and Biostatistics, Seattle, Washington and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cancer Research and Biostatistics, Seattle, Washington and","institution_ids":["https://openalex.org/I4210101190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007261675","display_name":"Guido J. K. Tricot","orcid":"https://orcid.org/0000-0002-3111-9739","observed_orcids":["https://orcid.org/0000-0002-3111-9739"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guido Tricot","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000879635","display_name":"Bart Barlogie","orcid":"https://orcid.org/0000-0001-6116-1017","observed_orcids":["https://orcid.org/0000-0001-6116-1017"]},"institutions":[{"id":"https://openalex.org/I79620101","display_name":"University of Arkansas for Medical Sciences","ror":"https://ror.org/00xcryt71","country_code":"US","type":"education","lineage":["https://openalex.org/I79620101"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bart Barlogie","raw_affiliation_strings":["2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas","institution_ids":["https://openalex.org/I79620101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.6823,"has_fulltext":false,"cited_by_count":102,"citation_normalized_percentile":{"value":0.97048762,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"13","issue":"23","first_page":"7073","last_page":"7079"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8769999742507935},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.8379999995231628},{"id":"https://openalex.org/keywords/prognostic-subgroups","display_name":"prognostic subgroups","score":0.8920000195503235},{"id":"https://openalex.org/keywords/high-risk-subgroups","display_name":"high-risk subgroups","score":0.7549999952316284},{"id":"https://openalex.org/keywords/tandem-autologous-transplantation","display_name":"tandem autologous transplantation","score":0.8690000176429749},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9340000152587891},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.5550000071525574},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7419992685317993},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7345457673072815},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6614305377006531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6436911225318909},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5374003648757935},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5150184631347656},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.5003311634063721},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.47523072361946106},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.47265708446502686},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4652705192565918},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.46483302116394043},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.45950764417648315},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.45564350485801697},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3474547266960144},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.21811005473136902},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1326848864555359},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08284014463424683},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013792","descriptor_name":"Thalidomide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014182","descriptor_name":"Transplantation, Autologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-07-0527","doi":"https://doi.org/10.1158/1078-0432.ccr-07-0527","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-07-0527","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:18056185","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18056185","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4818362736","display_name":"Growth Control in Multiple Myeloma","funder_award_id":"P01CA055819","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G85899172","display_name":"NEK2 Over-expression Causes Drug Resistance in Myeloma","funder_award_id":"R01CA152105","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W181450122","https://openalex.org/W1595870389","https://openalex.org/W1973617793","https://openalex.org/W1978377409","https://openalex.org/W1978850023","https://openalex.org/W1979300931","https://openalex.org/W1982499121","https://openalex.org/W1989908751","https://openalex.org/W1997001746","https://openalex.org/W2056955741","https://openalex.org/W2059990028","https://openalex.org/W2087824134","https://openalex.org/W2096087418","https://openalex.org/W2103114868","https://openalex.org/W2106462703","https://openalex.org/W2113424017","https://openalex.org/W2136373453","https://openalex.org/W2137791470","https://openalex.org/W2150997370","https://openalex.org/W2166517289","https://openalex.org/W2333363976","https://openalex.org/W2587839184","https://openalex.org/W3041047318","https://openalex.org/W3147894994","https://openalex.org/W4236730981"],"related_works":["https://openalex.org/W4233732954","https://openalex.org/W2014946770","https://openalex.org/W4405047787","https://openalex.org/W2547392879","https://openalex.org/W3124391571","https://openalex.org/W4230542662","https://openalex.org/W2586820217","https://openalex.org/W2136810538","https://openalex.org/W2614471822","https://openalex.org/W2063343795"],"abstract_inverted_index":{"EXPERIMENTAL":[0],"DESIGN:":[1],"To":[2],"determine":[3],"whether":[4,128],"the":[5,41,56,102,117,147,173],"clinical":[6,181],"benefit":[7,96,171],"of":[8,17,44,47,58,77,87,97,106,108,119,149,155,157,169,180],"complete":[9],"remission":[10],"(CR)":[11],"may":[12],"depend":[13],"on":[14,49,165,186],"prognostic":[15,42,60],"subgroups":[16],"patients":[18,27,75,109,120],"with":[19,28,121],"multiple":[20],"myeloma.":[21],"PATIENTS":[22],"AND":[23],"METHODS:":[24],"Newly":[25],"diagnosed":[26],"myeloma":[29],"received":[30],"a":[31,91,150,178,191],"tandem":[32],"autotransplant":[33],"regimen.":[34],"Using":[35],"multivariate":[36],"regression":[37],"analyses,":[38],"we":[39],"examined":[40],"implications":[43],"time-dependent":[45],"onset":[46],"CR":[48,73,98,131],"overall":[50],"survival":[51,54,92,126,162],"and":[52,63],"event-free":[53,94],"in":[55,159,172],"context":[57],"standard":[59],"factors":[61],"(SPF)":[62],"gene":[64,88,143],"expression":[65,144],"profiling-derived":[66],"data":[67],"available":[68],"for":[69,193],"326":[70],"patients.":[71],"RESULTS:":[72],"benefited":[74],"regardless":[76],"risk":[78],"status":[79],"when":[80],"only":[81,99],"SPFs":[82],"were":[83],"examined.":[84],"With":[85],"knowledge":[86],"array":[89],"data,":[90],"(and":[93],"survival)":[95],"pertained":[100],"to":[101,142,177],"small":[103,151],"high-risk":[104,153],"subgroup":[105,154],"13%":[107,156],"(hazard":[110,134],"ratio,":[111,135],"0.23;":[112],"P":[113,137],"=":[114,138],"0.001),":[115],"whereas":[116],"majority":[118],"low-risk":[122],"disease":[123],"had":[124],"similar":[125],"expectations":[127],"or":[129],"not":[130],"was":[132],"achieved":[133],"0.68;":[136],"0.128).":[139],"CONCLUSIONS:":[140],"Access":[141],"information":[145],"permitted":[146],"recognition":[148],"very":[152],"patients,":[158],"whom":[160],"prolonged":[161],"critically":[163],"depended":[164],"achieving":[166],"CR.":[167],"Absence":[168],"such":[170],"remainder":[174],"should":[175],"lead":[176],"reassessment":[179],"trial":[182],"designs":[183],"that":[184],"rely":[185],"this":[187],"end":[188],"point":[189],"as":[190],"surrogate":[192],"long-term":[194],"prognosis.":[195]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2135326558","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
